Invitrogen Corporation Exclusively Licenses Novel Click Chemistry-Based Cell Proliferation Assays from Harvard University

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announces the exclusive license of unique cell proliferation assays based on “click” chemistry from Harvard University. The license enhances Invitrogen’s growing portfolio of intellectual property surrounding click chemistry, originally developed by Nobel Laureate K. Barry Sharpless’ laboratory at The Scripps Research Institute in La Jolla, CA.